A phase II study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer

Category Primary study
JournalJournal of Clinical Oncology
Year 2022
This article has no abstract
Epistemonikos ID: bae7bdcd1ea0b3a27d363963a644aeca14573677
First added on: Feb 13, 2025